Keyphrases
Acute Lymphoblastic Leukemia
70%
Pediatric Acute Lymphoblastic Leukemia
40%
Physical Frailty
33%
Sarcopenia
30%
Confidence Interval
25%
Hunger
21%
Frailty
20%
Neurobehavior
18%
Odds Ratio
17%
Muscle Alterations
16%
Steroid-induced
16%
Mineralocorticoid Receptor
16%
Cytotoxicity
16%
Muscle Ultrasound
16%
Leptin
16%
Double-blind Randomized Controlled Trial
16%
Prospective Cohort Study
16%
Crossover Design
16%
Hydrocortisone
16%
Neurobehavioral Problems
13%
Fat Mass
12%
Placebo
9%
Maintenance Therapy
8%
Pre-frailty
8%
Appendicular Skeletal muscle Mass
7%
Muscle Strength
7%
Walking Performance
7%
Slow Walking
7%
Low muscle Mass
7%
Sleep Problems
6%
Dexamethasone Treatment
6%
Frailty Assessment
6%
Muscle Atrophy
6%
Grip Strength
5%
Leukemia Therapy
5%
Prognostic Factors
5%
Lower Limb Strength
5%
Bioelectrical Impedance Analysis
5%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Dexamethasone
66%
Pediatrics
41%
Frailty
33%
Sarcopenia
25%
Side Effect
21%
Randomized Controlled Trial
18%
Prospective Study
18%
Skeletal Muscle
16%
Mineralocorticoid Receptor
16%
Hydrocortisone
16%
Cytotoxicity
16%
Leptin
16%
Ultrasonography of Muscle
16%
Prospective Cohort Study
16%
Odds Ratio
12%
Muscle Strength
12%
Maintenance Therapy
11%
Body Mass Index
10%
Placebo
8%
Knee
8%
Physical Performance
8%
Physical Activity
6%
Hand Grip
5%
Drug Megadose
5%
Nursing and Health Professions
Acute Lymphoblastic Leukemia
50%
Dexamethasone
33%
Confidence Interval
18%
Hydrocortisone
16%
Side Effect
16%
Frailty
16%
Muscle Mass
14%
Sarcopenia
8%
Placebo
8%
Muscle Strength
8%
Odds Ratio
6%
Maintenance Therapy
5%
